Alimentary Pharmacology & Therapeutics

Review article: herbal treatment in gastrointestinal and liver disease—benefits and dangers
pp. 1239-1252(14)
Authors: Langmead, L.; Rampton, D. S.

Review article: current therapeutic options for radiation proctopathy
pp. 1253-1262(10)
Authors: Hong, J. J.; Park, W.; Ehrenpreis, E. D.

Review article: over-the-counter drugs and the gastrointestinal tract
pp. 1263-1270(8)
Authors: Sheen, C. L.; Colin-Jones, D. G.

Review article: pathogenesis of Helicobacter pylori-induced gastric inflammation
pp. 1271-1290(20)
Authors: Israel, D. A.; Peek, R. M.

H₂-receptor antagonists in the treatment of functional (nonulcer) dyspepsia: a meta-analysis of randomized controlled clinical trials
pp. 1291-1299(9)
Authors: Redstone, H. A.; Barrowman, N.; Veldhuyzen Van Zanten, S. J. O.

Chronic use of non-steroidal anti-inflammatory drugs does not alter colonic mucosa of patients without diarrhoea
pp. 1301-1306(6)
Authors: Beaugerie, L.; Berenbaum, F.; Berrebi, D.; Gendre, J. P.; Prier, A.; Kaplan, G.; Chatelet, F. P.

Safety and efficacy of azathioprine in the maintenance of ciclosporin-induced remission of ulcerative colitis
pp. 1307-1311(5)
Authors: Actis, G. C.; Bresso, F.; Astegiano, M.; Demarchi, B.; Sapone, N.; Boscaglia, C.; Rizzetto, M.

Extracorporeal photochemotherapy in patients with steroid-dependent Crohn's disease: a prospective pilot study
pp. 1313-1322(10)
Authors: Reinisch, W.; Nahavandi, H.; Santella, R.; Zhang, Y.; Gasché, C.; Moser, G.; Waldhör, T.; Gangl, A.; Vogelsang, H.; Knobler, R.

Lack of efficacy of ridogrel, a thromboxane synthase inhibitor, in a placebo-controlled, double-blind, multi-centre clinical trial in active Crohn's disease
pp. 1323-1329(7)
Authors: Carty, E.; Rampton, D. S.; Schneider, H.; Rutgeerts, P.; Wright, J. P.

Maintenance of Crohn's disease over 12 months: fixed versus flexible dosing regimen using budesonide controlled ileal release capsules
pp. 1331-1341(11)
Authors: Green, J. R. B.; Lobo, A. J.; Giaffer, M.; Travis, S.; Watkins, H. C.

Decreasing oesophageal acid exposure in patients with GERD: a comparison of rabeprazole and omeprazole
pp. 1343-1350(8)
Authors: Galmiche, J. P.; Zerbib, F.; Ducrottè, P.; Fournet, J.; Rampal, P.; Avasthy, N.; Humphries, T. J.

Bedtime H₂ blockers improve nocturnal gastric acid control in GERD patients on proton pump inhibitors
pp. 1351-1356(6)
Authors: Xue, S.; Katz, P. O.; Banerjee, P.; Tutuian, R.; Castell, D. O.

The effect of cholecystokinin antagonism on postprandial lower oesophageal sphincter function in asymptomatic volunteers and patients with reflux disease
pp. 1357-1364(8)
Authors: Trudgill, N. J.; Hussain, F. N.; Moustafa, M.; Ajjan, R.; D'Amato, M.; Riley, S. A.

Synergy between low-dose ranitidine and antacid in decreasing gastric and oesophageal acidity and relieving meal-induced heartburn
pp. 1365-1374(10)
Authors: Robinson, M.; Rodriguez-Stanley, S.; Ciociola, A. A.; Filinto, J.; Zubaidi, S.; Miner, P. B.; Gardner, J. D.

Influence of pantoprazole on oesophageal motility, and bile and acid reflux in patients with oesophagitis
pp. 1375-1384(10)
Authors: Netzer, P.; Gut, A.; Brundler, R.; Gaia, C.; Halter, F.; Inauen, W.

The role of age and salivation in acid clearance in symptomatic patients with gastro-oesophageal reflux disease
pp. 1385-1388(4)
Authors: Orr, W. C.; Chen, C.-L.; Sloan, S.

Randomized controlled trial comparing botulinum toxin injection to pneumatic dilatation for the treatment of achalasia
pp. 1389-1396(8)
Authors: Mikaeli, J.; Fazel, A.; Montazeri, G.; Yaghoobi, M.; Malekzadeh, R.

Lansoprazole in children: pharmacokinetics and efficacy in reflux oesophagitis
pp. 1397-1402(6)
Authors: Faure, C.; Michaud, L.; Khan Shaghaghi, E.; Popon, M.; Laurence, M.; Mougenot, J. F.; Hankard, R.; Navarro, J.; Jacqz-Aigrain, E.

When William of Ockham meets Thomas Bayes: finding a few diagnoses among a great many symptoms
pp. 1403-1407(5)
Author: Sonnenberg, A.

Randomized clinical study of nitazoxanide compared to metronidazole in the treatment of symptomatic giardiasis in children from Northern Peru
pp. 1409-1415(7)
Authors: Ortiz, J. J.; Ayoub, A.; Gargala, G.; Chegne, N. L.; Favennec, L.

In vivo and in vitro permeability in coeliac disease
pp. 1417-1425(9)
Authors: Vogelsang, H.; Schwarzenhofer, M.; Steiner, B.; Wyatt, J.; Oberhuber, G.

Ten-year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double-blind, placebo-controlled trial on symptomatic patients
pp. 1427-1434(8)
Authors: Battezzati, P. M.; Zuin, M.; Crosignani, A.; Allocca, M.; Invernizzi, P.; Selmi, C.; Villa, E.; Podda, M.

Octreotide increases the proportions of arachidonic acid-rich phospholipids in gall-bladder bile
pp. 1435-1443(9)
Authors: Pereira, S. P.; Hussaini, S. H.; Murphy, G. M.; Wass, J. A. H.; Dowling, R. H.

Influence of anti-Helicobacter triple-therapy with metronidazole, omeprazole and clarithromycin on intestinal microflora
pp. 1445-1452(8)
Authors: Bühling, A.; Radun, D.; Müller, W. A.; Malfertheiner, P.

Outcomes of Helicobacter pylori treatment in community practice and impact of therapeutic effectiveness information on physician behaviour
pp. 1453-1458(6)
Authors: Fennerty, M. B.; Magaret, N.; Dalros, L.; Faigel, D.; Lieberman, D.; Shaw, M.

Epidermal growth factor and its receptor in chronic active gastritis and gastroduodenal ulcer before and after Helicobacter pylori eradication
pp. 1459-1465(7)
Authors: Chun Yu Wong, B.; Ping Wang, W.; Hau Leung So, W.; Shin, V. Y.; Man Wong, W.; Man Yee Fung, F.; Shiu Lam Liu, E.; Mo Hiu, W.; Kum Lam, S.; Hin Cho, C.

Apoptosis and proliferation in Helicobacter pylori-associated gastric intestinal metaplasia
pp. 1467-1472(6)
Authors: Leung, W. K.; Yu, J.; To, K. F.; Go, M. Y. Y.; Ma, P. K.; Chan, F. K. L.; Sung, J. J. Y.

Helicobacter pylori antimicrobial resistance in the United Kingdom: the effect of age, sex and socio-economic status
pp. 1473-1478(6)
Authors: Parsons, H. K.; Carter, M. J.; Sanders, D. S.; Winstanley, T.; Lobo, A. J.

Efficacy of triple therapy with rabeprazole for Helicobacter pylori infection and CYP2C19 genetic polymorphism
pp. 1479-1484(6)
Authors: Hokari, K.; Sugiyama, T.; Kato, M.; Saito, M.; Miyagishima, T.; Kudo, M.; Nishikawa, K.; Ishizuka, J.; Komatsu, Y.; Mizushima, T.; Kagaya, H.; Hige, S.; Takeda, H.; Asaka, M.

Intragastric distribution of Helicobacter pylori during short-term omeprazole therapy: study using Carnoy's fixation and immunohistochemistry for detection of bacteria
pp. 1485-1491(7)
Authors: Ishihara, S.; Okuyama, T.; Ishimura, N.; Ono, M.; Hashimoto, T.; Kazumori, H.; Kaji, T.; Sato, H.; Fujishiro, H.; Adachi, K.; Fukuda, R.; Kinoshita, Y.

Comparison of 1-week vs. 2- or 4-week therapy regimens with ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication
pp. 1493-1497(5)
Authors: Kamberoglou, D.; Polymeros, D.; Sanidas, I.; Doulgeroglou, V.; Savva, S.; Patra, E.; Tzias, V.

Twenty-minute 50 mg ¹³C-urea breath test without test meal for the diagnosis of Helicobacter pylori infection in Chinese
pp. 1499-1504(6)
Authors: Wong, W. M.; Wong, B. C. Y.; Li, T. M.; Wong, K. W.; Cheung, K. L.; Fung, F. M. Y.; Xia, H. H. X.; Lam, S. K.

Effect of Helicobacter pylori eradication on expression of cyclin D2 and p27 in gastric intestinal metaplasia
pp. 1505-1511(7)
Authors: Yu, J.; Leung, W. K.; Ng, E. K. W.; To, K. F.; Ebert, M. P. A.; Go, M. Y. Y.; Chan, W. Y.; Chan, F. K. L.; Chung, S. C. S.; Malfertheiner, P.; Sung, J. J. Y.

Corrigendum
pp. 1513-1513(1)

Corrigendum
pp. 1513-1513(1)